Max Robotics — Global Service Robot Directory + US Certification

About

Michael Kulik is a pioneering researcher at the intersection of stem cell biology, bioprocess engineering, and laboratory automation. His work focuses on developing automated, scalable manufacturing systems for human induced pluripotent stem cells (hiPSCs) and advanced therapeutic medicinal products (ATMPs), addressing one of the most pressing bottlenecks in modern regenerative medicine. Kulik's most influential contribution, "The StemCellFactory" (2020, 42 citations), introduced a modular, automated platform capable of generating and expanding hiPSC cohorts at a scale previously unattainable, enabling more statistically robust disease modeling across diverse genetic backgrounds. This work builds on his earlier vision for robotic stem cell manufacturing, articulated in his 2016 paper on automated robotic factories (31 citations), which helped establish the conceptual and technical framework for the field. His subsequent research has refined these approaches further, including a fully closed, needle-to-needle robotic manufacturing workflow for cell therapies (2022, 17 citations) and the AUTOSTEM platform for scalable mesenchymal stromal cell production (2017, 10 citations). Together, these contributions represent a coherent and impactful research program aimed at replacing costly, high-risk manual processes with reliable, GMP-compliant automated systems — accelerating the path from laboratory discovery to clinical application.